– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...
What are the key questions that drug delivery developers should ask when developing drugs for folks treating chronic diseases or illnesses? The first question a company should be asking themselves is ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results